awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38547047-9E7E1A6C-1AC8-498B-A75E-002E089A2264
Q38547047-9E7E1A6C-1AC8-498B-A75E-002E089A2264
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38547047-9E7E1A6C-1AC8-498B-A75E-002E089A2264
Current challenges and controversies in the management of chronic spontaneous urticaria.
P2860
Q38547047-9E7E1A6C-1AC8-498B-A75E-002E089A2264
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38547047-9E7E1A6C-1AC8-498B-A75E-002E089A2264
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cf0384dbf9b1664cfb5c4980dbd4b954c74c55e3
P2860
Long-term efficacy of fixed-dose omalizumab for patients with severe chronic spontaneous urticaria.